rs115281140

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001083116.3(PRF1):​c.435G>A​(p.Val145Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00713 in 1,614,214 control chromosomes in the GnomAD database, including 76 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 21 hom., cov: 32)
Exomes 𝑓: 0.0067 ( 55 hom. )

Consequence

PRF1
NM_001083116.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.388

Publications

1 publications found
Variant links:
Genes affected
PRF1 (HGNC:9360): (perforin 1) This gene encodes a protein with structural similarities to complement component C9 that is important in immunity. This protein forms membrane pores that allow the release of granzymes and subsequent cytolysis of target cells. Whether pore formation occurs in the plasma membrane of target cells or in an endosomal membrane inside target cells is subject to debate. Mutations in this gene are associated with a variety of human disease including diabetes, multiple sclerosis, lymphomas, autoimmune lymphoproliferative syndrome (ALPS), aplastic anemia, and familial hemophagocytic lymphohistiocytosis type 2 (FHL2), a rare and lethal autosomal recessive disorder of early childhood. [provided by RefSeq, Aug 2017]
PALD1 (HGNC:23530): (phosphatase domain containing paladin 1) Predicted to enable protein tyrosine phosphatase activity. Predicted to be involved in peptidyl-tyrosine dephosphorylation. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 10-70600468-C-T is Benign according to our data. Variant chr10-70600468-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.388 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0112 (1712/152326) while in subpopulation AFR AF = 0.0225 (937/41568). AF 95% confidence interval is 0.0213. There are 21 homozygotes in GnomAd4. There are 783 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001083116.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRF1
NM_001083116.3
MANE Select
c.435G>Ap.Val145Val
synonymous
Exon 2 of 3NP_001076585.1P14222
PRF1
NM_005041.6
c.435G>Ap.Val145Val
synonymous
Exon 2 of 3NP_005032.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRF1
ENST00000441259.2
TSL:5 MANE Select
c.435G>Ap.Val145Val
synonymous
Exon 2 of 3ENSP00000398568.1P14222
PRF1
ENST00000373209.2
TSL:1
c.435G>Ap.Val145Val
synonymous
Exon 2 of 3ENSP00000362305.1P14222
PRF1
ENST00000862973.1
c.435G>Ap.Val145Val
synonymous
Exon 1 of 2ENSP00000533032.1

Frequencies

GnomAD3 genomes
AF:
0.0112
AC:
1706
AN:
152208
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0225
Gnomad AMI
AF:
0.123
Gnomad AMR
AF:
0.00864
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00621
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00685
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00604
AC:
1518
AN:
251448
AF XY:
0.00541
show subpopulations
Gnomad AFR exome
AF:
0.0229
Gnomad AMR exome
AF:
0.00627
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.00618
Gnomad OTH exome
AF:
0.00668
GnomAD4 exome
AF:
0.00670
AC:
9793
AN:
1461888
Hom.:
55
Cov.:
34
AF XY:
0.00655
AC XY:
4761
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0228
AC:
765
AN:
33480
American (AMR)
AF:
0.00700
AC:
313
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00536
AC:
462
AN:
86256
European-Finnish (FIN)
AF:
0.000786
AC:
42
AN:
53420
Middle Eastern (MID)
AF:
0.00641
AC:
37
AN:
5768
European-Non Finnish (NFE)
AF:
0.00695
AC:
7733
AN:
1112008
Other (OTH)
AF:
0.00725
AC:
438
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
635
1270
1906
2541
3176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0112
AC:
1712
AN:
152326
Hom.:
21
Cov.:
32
AF XY:
0.0105
AC XY:
783
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0225
AC:
937
AN:
41568
American (AMR)
AF:
0.00863
AC:
132
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00663
AC:
32
AN:
4828
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10626
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00685
AC:
466
AN:
68024
Other (OTH)
AF:
0.0113
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
88
176
263
351
439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00749
Hom.:
9
Bravo
AF:
0.0127
Asia WGS
AF:
0.00577
AC:
20
AN:
3478
EpiCase
AF:
0.00654
EpiControl
AF:
0.00551

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Familial hemophagocytic lymphohistiocytosis 2 (3)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Autoinflammatory syndrome (1)
-
-
1
Lymphoma, non-Hodgkin, familial (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.95
DANN
Benign
0.50
PhyloP100
0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115281140; hg19: chr10-72360224; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.